1[1]Mahaffey KW, Granger CB, Toth CA, et al. Diabetic retinopathy should not be a contraindication to thrombolytic therapy for actue myocardial infarction: review of occular hemorrhage incidence and location in the GUSTO-Itrial-Global utilization of streptokinase and t-PA for occluded coronary arteries. J Am Coll Cardiol, 1997,30:1606.
2[2]Mark KH, Moliterno DJ, Granger CB, et al. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of actue myocardial infarction. J Am Coll Cardiol, 1997, 30:171.
